{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00533",
      "entity_text" : "EGFR",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_0320" ],
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0160" ]
    }
  },
  "verbose_text" : "In the present study, to clarify the anti-tumor mechanisms of cetuximab, we evaluated the KRAS / BRAF status, phosphorylation level of the EGFR pathway, and the tumor suppression effect in vivo, using a human colon cancer cell line HT29, which exhibited the highest EGFR expression in response to the cetuximab therapy among the 6 colorectal cancer cell lines tested.",
  "reading_complete" : "2020-08-03T13:44:34Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:41:41Z",
  "trigger" : "level",
  "evidence" : [ "level of the EGFR" ],
  "pmc_id" : "3118158",
  "score" : 0
}